As of 2024-12-15, the Relative Valuation of MustGrow Biologics Corp (MGRO.CN) is (0.36) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 3.35 CAD, the upside of MustGrow Biologics Corp based on Relative Valuation is -110.9%.
The range of the Relative Valuation is (0.34) - (0.36) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 2.3x - 3.4x | 2.8x |
| Forward P/E multiples | 1.6x - 2.4x | 2.0x |
| Fair Price | (0.34) - (0.36) | (0.36) |
| Upside | -110.2% - -110.8% | -110.9% |
| Date | P/E |